MedTrace Logo

Study of Circulating Tumoral DNA in Ovarian Cancer

NCT01350908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-01-31

No results posted yet for this study

Summary

Circulating tumor DNA detection and quantification in patients with ovarian cancer.

Conditions

Interventions

OTHER

Blood sampling

30mL of peripherical blood will be collected specially for the study. It's an additional blood sampling compare to the normal follow up of the patient.

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • LANTZ Olivier, MD · Institut Curie

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2015-01-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01350908 on ClinicalTrials.gov